This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n6http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q90351990
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel scientific article published on 26 September 2019 artículu científicu espublizáu en setiembre de 2019 наукова стаття, опублікована 26 вересня 2019
p:P577
wds:Q90351990-85A3137B-4434-4520-9014-F02072553544
wdt:P577
2019-09-26T00:00:00Z
p:P2093
wds:Q90351990-FC1F3310-0FBE-4F7D-B93E-9B961B952083 wds:Q90351990-FA721A2D-E5C7-4183-84EC-4732123FB4CB wds:Q90351990-F8640E4B-989B-49BB-887E-8D446643044F wds:Q90351990-709E1193-32EA-4074-A5AB-21F64853E35C wds:Q90351990-E4143302-E849-457E-A810-8389D6997D21 wds:Q90351990-50BBD150-45C1-496A-A89D-DAE9982BFF26 wds:Q90351990-266E1B13-FFB1-46D9-96F1-52096D93E4F4
wdt:P2093
Yasir Alayed Hans T Chung Gerard Morton Laura D'Alimonte Masoom Haider Joelle Helou Liying Zhang
rdfs:label
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial
skos:prefLabel
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial
schema:name
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial
p:P50
wds:Q90351990-52A610EC-86F7-4C52-ABA9-B44EC6CD004C wds:Q90351990-F43E95C6-415F-4533-B537-E67DAD739D16 wds:Q90351990-FD5339BC-E350-42CD-8F62-4806F87A3C6E
wdt:P50
wd:Q86168938 wd:Q57612821 wd:Q39879441
p:P1476
wds:Q90351990-51F57C91-7D58-4A63-B41F-801DB45DE1A0
wdt:P1476
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial
p:P304
wds:Q90351990-BAFFECDA-F978-4D4D-9A68-BA51BE3E33EF
wdt:P304
144-148
p:P31
wds:Q90351990-0B07B20F-1A6E-4BFA-99E6-9721FBC76E38
wdt:P31
wd:Q13442814
p:P921
wds:Q90351990-02E4F4A5-40E4-4931-9195-4F6E2EF3F637
wdt:P921
wd:Q42824440
p:P698
wds:Q90351990-4BF5C2E7-2604-4036-A323-04EE30BE5EFC
wdtn:P698
n12:31564554
wdt:P698
31564554
p:P1433
wds:Q90351990-98067DE6-C292-4B55-98EA-14B795970450
wdt:P1433
wd:Q14251029
p:P478
wds:Q90351990-D6D032CA-C6C4-421B-807F-8A3457D89F83
wdt:P478
141
p:P356
wds:Q90351990-08182AE4-51B4-4BD5-BD6E-337388346C34
wdtn:P356
n6:J.RADONC.2019.09.011
wdt:P356
10.1016/J.RADONC.2019.09.011